Wesolowski R - Search Results

1

Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibition.

Madison AA, Andridge R, Renna ME, Sheridan JF, Lustberg M, Ramaswamy B, Wesolowski R, Williams NO, Sardesai SD, Noonan AM, Reinbolt RE, Cherian MA, Malarkey WB, Kiecolt-Glaser JK. Madison AA, et al. Among authors: wesolowski r. J Affect Disord. 2023 Dec 1;342:1-9. doi: 10.1016/j.jad.2023.09.008. Epub 2023 Sep 7. J Affect Disord. 2023. PMID: 37683942 Clinical Trial.

2

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.

Waks AG, Stover DG, Guerriero JL, Dillon D, Barry WT, Gjini E, Hartl C, Lo W, Savoie J, Brock J, Wesolowski R, Li Z, Damicis A, Philips AV, Wu Y, Yang F, Sullivan A, Danaher P, Brauer HA, Osmani W, Lipschitz M, Hoadley KA, Goldberg M, Perou CM, Rodig S, Winer EP, Krop IE, Mittendorf EA, Tolaney SM. Waks AG, et al. Among authors: wesolowski r. Clin Cancer Res. 2019 Aug 1;25(15):4644-4655. doi: 10.1158/1078-0432.CCR-19-0173. Epub 2019 May 6. Clin Cancer Res. 2019. PMID: 31061067 Free PMC article.

3

Phenoxodiol: isoflavone analog with antineoplastic activity.

Choueiri TK, Wesolowski R, Mekhail TM. Choueiri TK, et al. Among authors: wesolowski r. Curr Oncol Rep. 2006 Mar;8(2):104-7. doi: 10.1007/s11912-006-0044-2. Curr Oncol Rep. 2006. PMID: 16507219 Review.

4

Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon.

Burkart J, Owen D, Shah MH, Abdel-Misih SRZ, Roychowdhury S, Wesolowski R, Haraldsdottir S, Reeser JW, Samorodnitsky E, Smith A, Konda B. Burkart J, et al. Among authors: wesolowski r. J Natl Compr Canc Netw. 2018 Sep;16(9):1035-1040. doi: 10.6004/jnccn.2018.7043. J Natl Compr Canc Netw. 2018. PMID: 30181415

5

A young woman with a breast mass: What every internist should know.

Wesolowski R, Budd GT. Wesolowski R, et al. Cleve Clin J Med. 2010 Aug;77(8):537-46. doi: 10.3949/ccjm.77a.09095. Cleve Clin J Med. 2010. PMID: 20682516 Free article. No abstract available.

6

Is there a role for second-line chemotherapy in advanced gastric cancer?

Wesolowski R, Lee C, Kim R. Wesolowski R, et al. Lancet Oncol. 2009 Sep;10(9):903-12. doi: 10.1016/S1470-2045(09)70136-6. Lancet Oncol. 2009. PMID: 19717092 Review.

7

Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC regimen) in advanced malignancies.

Wesolowski R, Peereboom D, Weiss P, Elson P, Thomas Budd G. Wesolowski R, et al. Invest New Drugs. 2010 Aug;28(4):502-8. doi: 10.1007/s10637-009-9258-0. Epub 2009 May 12. Invest New Drugs. 2010. PMID: 19434371 Clinical Trial.

8

Use of chemotherapy for patients with bone and soft-tissue sarcomas.

Wesolowski R, Budd GT. Wesolowski R, et al. Cleve Clin J Med. 2010 Mar;77 Suppl 1:S23-6. doi: 10.3949/ccjm.77.s1.05. Cleve Clin J Med. 2010. PMID: 20179184 Free article. Review.

9

Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.

Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GT, Stark GR, Eng C. Tan MH, et al. Among authors: wesolowski r. Breast Cancer Res Treat. 2012 Feb;131(3):849-58. doi: 10.1007/s10549-011-1500-8. Epub 2011 Apr 9. Breast Cancer Res Treat. 2012. PMID: 21479552 Free PMC article.

10

Hepatocellular carcinoma metastatic to uvea.

Wesolowski R, Chung JY, Singh A, Kim R. Wesolowski R, et al. Retin Cases Brief Rep. 2010 Spring;4(2):178-80. doi: 10.1097/ICB.0b013e31819f1fd3. Retin Cases Brief Rep. 2010. PMID: 25390396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page